MoneyWorks4Me

Kopran - Quaterly Results

16 May 2024 Evaluate
The revenue for the March 2024 quarter is pegged at Rs. 906.23 millions, about 12.96% up against Rs. 802.28 millions recorded during the year-ago period.The Net Profit of the company vaulted to 177.44% to Rs. 153.09  millions from Rs. 55.18 millions in the previous quarter.Operating profit for the quarter ended March 2024 rose to 234.90 millions as compared to 94.37 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 906.23 802.28 12.96 3374.56 2730.95 23.57 3374.56 2730.95 23.57
Other Income 81.49 20.74 292.91 167.11 160.86 3.89 167.11 160.86 3.89
PBIDT 234.90 94.37 148.91 536.37 439.99 21.91 536.37 439.99 21.91
Interest 17.79 8.41 111.53 45.01 26.72 68.45 45.01 26.72 68.45
PBDT 217.11 85.96 152.57 491.36 413.27 18.90 491.36 413.27 18.90
Depreciation 11.62 10.89 6.70 46.20 44.12 4.71 46.20 44.12 4.71
PBT 205.49 75.07 173.73 445.16 369.15 20.59 445.16 369.15 20.59
TAX 52.40 19.89 163.45 98.79 56.63 74.45 98.79 56.63 74.45
Deferred Tax 0.10 0.22 -54.55 -2.03 -2.09 -2.87 -2.03 -2.09 -2.87
PAT 153.09 55.18 177.44 346.37 312.52 10.83 346.37 312.52 10.83
Equity 482.11 482.11 0.00 482.11 482.11 0.00 482.11 482.11 0.00
PBIDTM(%) 25.92 11.76 120.36 15.89 16.11 -1.35 15.89 16.11 -1.35
Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..